Patent File Information
Application Information
Applicants
Person No Name Address
7244689 GENZYME CORPORATION
Inventors
Person No Name Address
7244669 ELYSE BOURQUE 728 GEORGIA STREET BLAINE, WASHINGTON 98230 A.B.D.
7244688 OXANA BESKROVNAYA C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244671 CASSANDRA CELATKA 13 OCEAN AVENUE HULL, MASSACHUSETTS 02045 A.B.D.
7244672 H SENG CHENG C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244673 BRADFORD HIRTH C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244674 ANDREW GOOD C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244675 KATHERINE JANCSICS 32 HOPKINS WILMINGTON, MASSACHUSETTS 01887 A.B.D.
7244677 JOHN MARSHALL C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244678 MARKUS METZ C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244679 K RONALD SCHEULE C/O SANOFI 55 CORPORATE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244680 RENATO SKERLJ 13 CROCKER CIRCLE NEWTON, MASSACHUSETTS 02465 A.B.D.
7244682 YIBIN XIANG 24 MARSHALL PATH ACTON, MASSACHUSETTS 01720 A.B.D.
7244683 ZHONG ZHAO C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244684 JOHN LEONARD C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244685 THOMAS NATOLI C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244686 ELINA MAKINO C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244687 HERVE HUSSON C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55A-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
7244670 A MARIO CABRERA-SALAZAR C/O SANOFI 55 CORPORATE DRIVE MAIL STOP: 55-505A BRIDGEWATER, NEW JERSEY 08807 A.B.D.
Invention Information
Name Of Invention Glukosilseramid sentaz inhibitörleri
Summary Of Invention Buluş, tek başına veya enzim replasman tedavisi ile kombinasyon halinde, lizozomal depo hastalıkları gibi metabolik hastalıkların, kistik hastalığının tedavisine yönelik ve kanser tedavisine yönelik olarak faydalı glukosilseramid sentazın (GCS) inhibitörleri ile ilgilidir.
Attorney Information
Name TOLGA ÇAYLAK
DIŞ PATENT MARKA TESCİL ve DANIŞMANLIK HİZ. LTD. ŞTİ.
Address GİRNE MAH. ELİFLİ SOK. NO:27 BAY PLAZA KAT:5-6-7 MALTEPE/ İSTANBUL
Priority Information
Date of Priority Priority Number Country of Priority
11-09-2012 US 201261699714P US
Classes of The Invention
IPC
C07D453/02
A61P35/00
A61P25/00
A61K31/439
C07D471/08
A61K31/496
A61K31/497
A61K31/506
A61K31/5377
A61K31/55
A61K31/551
A61P3/00
A61P9/10
A61P13/12
A61P25/16
A61P25/28
A61P43/00
Patent Application Procedures
Date Date of Notification Operation Document
22-08-2024 Yıllık Ücret Ödeme Talebi
08-09-2023 Yıllık Ücret Ödeme Talebi
08-09-2022 Yıllık Ücret Ödeme Talebi
20-05-2022 Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
10-05-2022 EPO'dan Gelen Patent Fasikül
Publications
Publication Date Description
21-03-2025 Kullanma/Kullanmama Beyanı Verilmemiş Olan Başvuru veya Patent/Faydalı Modellerin İlanı
23-05-2022 Avrupa Patent Fasiküllerinin İlanı
Payment Dates
Row Year Payment Date Amount Paid (₺)
10 2022 08-09-2022 1610.0
11 2023 08-09-2023 3974.03
12 2024 22-08-2024 7230.0